BD, Quest diagnostics incorporated and THERMO FISHER SCIENTIFIC, INC. are Dominating the Global Swabs Collection Kits Market in 2020

Global Swabs Collection Kits Market is expected to grow with the CAGR of 8.9% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-swabs-collection-kits-market

Global Swabs Collection Kits Market is a highly consolidated market, which includes specific number of key players as well as local players. The high demand for swabs collection kits due to the COVID-19 pandemic is putting pressure on the key players to bridge the gap and meet this high demand while maintaining patient care quality.

The major players dealing in Global Swabs Collection Kits Market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.

For instance,

  • In July 2020, BD launched the rapid point-of-care antigen testing kits for the detection of novel coronavirus. The test BD Veritor Plus System has helped in detection of coronavirus and BD has supplied swabs for sample collection of millions of people. This has helped in the growth of the market due to surge in demand for these tests.

BD, is dominating player in Global Swabs Collection Kits Market. The other key players existing in the market includes Medline Industries, Inc., Starplex Scientific Inc., GeneDx, Inc., Puritan Medical Products, Quidel Corporation, Titan Biotech Ltd HiMedia Laboratories, VIRCELL S.L., DiaSorin Molecular LLC, COPAN Diagnostics Inc., Lucence Health Inc., BTNX Inc., Norgen Biotek Corp., Thermo Fisher Scientific Inc., Hologic, Inc., Path-Tec, LLC, Quest Diagnostics Incorporated, MWE, BioCat GmbH, Miraclean Technology Co.,Ltd. and Hardy Diagnostics among others

Swabs Collection Kits MarketBD

BD has headquartered in New Jersey, U.S. was founded in 1897. The company is engaged in the development, manufacture and sale of broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions also provide customer solutions that are focused on improving medication management and patient safety among others.

  • In July 2020, BD launched the rapid point-of-care antigen testing kits for the detection of novel coronavirus. The test BD Veritor Plus System has helped in detection of coronavirus and BD has supplied swabs for sample collection of millions of people. This has helped in the growth of the market due to surge in demand for these tests.

The company has wide global presence across the world as North America, Europe, Asia-Pacific, South America, Middle East and Africa with its various subsidiaries such as Care Fusion (U.S.), C. R .Bard (U.S.), Accuri Cytometers Inc. (U.S.), Becton Dickson UK ltd. (U.K.) and Straub medical AG (Switzerland) among others.

Quest diagnostics incorporated

Quest diagnostics incorporated headquartered in New Jersey, U.S. was founded in year 1990The company engages in the provision for diagnostic testing, information and services. It operates through the diagnostic information services (DIS) and all other segments.

  • In September 2020, Quest Diagnostics Incorporated announced the launch of its three diagnostic kits. These test kits can provide combined diagnosis for Covid-19 along with respiratory viruses. The range of new kits include, cobas SARS-CoV-2 & Influenza A/B* (assay from Roche). These test kits have resulted in the growth of the market in the past year and the market may observe a steady growth in the coming years.

The company has wide global presence across the world as North America, Europe, Asia-Pacific, South America, Middle East and Africa with its various subsidiaries such as Quest Diagnostics Clinical Laboratories Inc. (Pennsylvania), Quest Diagnostics Nichols Institute  (California), Quest Diagnostics Holdings Incorporated (De) (Pennsylvania), Quest Diagnostics Llc (Connecticut), Quest Diagnostics MÚxico S. De R.L. De C.V.  (Mexico), among others

THERMO FISHER SCIENTIFIC, INC.

THERMO FISHER SCIENTIFIC, INC. is headquartered in Massachusetts, U.S. was founded in 2006. The company is focused on making the world healthier, cleaner and safer by accelerating life science research, solving complex analytical challenges and improving patients therapies and diagnostics.

  • In October 2020, Thermo Fisher Scientific, Inc. announced the expansion of its manufacturing unit in Lenexa, Kansas. Owing to rise in demand for sample testing kits during the Covid-19 pandemic, the company will be able to produce large number sample collection kits in the region. This will drive the growth of the market in fore coming years.

The company has wide global presence across the world as North America, Europe, Asia-Pacific, South America, Middle East and Africa with its various subsidiaries such as Thermo Electron North America LLC (U.S.), Fisher Scientific GmbH (Germany), Fisher Scientific Korea Ltd (Korea), Thermo Fisher Scientific Germany BV & Co KG (Germany), Thermo Fisher Scientific K.K. (Japan) among others.